This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Senior, M. Sovaldi makes blockbuster history, ignites drug pricing unrest. Nat Biotechnol 32, 501–502 (2014). https://doi.org/10.1038/nbt0614-501
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0614-501
This article is cited by
-
Why High Drug Pricing Is A Problem for Research Ethics
Journal of Bioethical Inquiry (2020)
-
The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration
Applied Health Economics and Health Policy (2019)
-
Drugmakers accused of exploiting orphan drug incentives, fueling price problem
Nature Biotechnology (2017)
-
$1-million price tag set for Glybera gene therapy
Nature Biotechnology (2015)